TsRNA-49-73-Glu-CTC: A promising serum biomarker in non-small cell lung cancer.
<h4>Objective</h4>Lung cancer has the highest incidence and mortality rates globally, with the majority of cases classified as non-small cell lung cancer (NSCLC). Due to the absence of specific tumor biomarkers, most lung cancer cases are diagnosed at an advanced stage. Therefore, the id...
Saved in:
| Main Authors: | Chenyu Li, Shenjie Zhong, Juan Chen, Xiaofeng Mu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0320187 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
tsRNA, cell death and disease: Connecting the dots
by: Xiaoyu Ma, et al.
Published: (2025-08-01) -
Identification of serum tsRNA-Thr-5-0015 and combined with AFP and PIVKA-II as novel biomarkers for hepatocellular carcinoma
by: Kangfeng Jin, et al.
Published: (2024-11-01) -
Maternal plasma extracellular vesicles tsRNA as potential biomarkers for assessing preterm labor risk
by: Xinrui Sun, et al.
Published: (2025-05-01) -
Research progress on the tsRNA biogenesis, function, and application in lung cancer
by: Yu Chen, et al.
Published: (2025-02-01) -
Intravenous injection of BMSCs modulate tsRNA expression and ameliorate lung remodeling in COPD mice
by: Ting Jin, et al.
Published: (2024-11-01)